Asia
Food ingredient specialist Holista CollTech Ltd (ASX:HCT, “Holista”) has partnered Bursa Malaysia-listed Kawan Food Berhad (“Kawan Food”) to produce healthy Asian flatbreads, including roti canai, roti and chappati, for local and international markets.
Eisai Co., Ltd. announced today that presentations on a series of abstracts highlighting the latest data from post-hoc analyses of a Phase III clinical study (REFLECT/Study 304) on its in-house discovered multiple receptor tyrosine kinase inhibitor lenvatinib mesylate will be presented during the 2019 Gastrointestinal Cancers Symposium (ASCO-GI) in San Francisco from January 17 to 19.
Eisai Co., Ltd. and Purdue Pharma L.P. today announced that a new drug application has been submitted to the U.S. Food and Drug Administration (FDA) for lemborexant, an investigational agent for sleep-wake regulation, seeking approval for the treatment of insomnia, a sleep-wake disorder.
Transoral approach aims to achieve scar-free surgery with minimal dissection
The rate of incidence of infection by Naegleria fowleri in the U.S. is very, very low. But there’s something about picking up an incurable, brain-eating amoeba by swimming in freshwater lakes and rivers that understandably freaks people out.
Wave Life Sciences is working to get its nucleic acid treatment, suvodirsen, for Duchenne muscular dystrophy (DMD) approved. DMD is a rare muscle-wasting disease that affects mostly boys, about 15,000 in the U.S.
After conducting a routine research-and-development review, Pfizer is easing away from preclinical biosimilar development. The bottom line is the company is ending five preclinical programs in its biosimilar area and cutting 150 positions.
Couples can choose the gender of the child based on the UAE rules and regulations
Aslan Pharmaceuticals’ first-line therapy for HER1/HER2 co-expressing cancer tumors failed to meet primary endpoints in a mid-stage trial after 12 weeks of treatment, the company announced Sunday.
In 2010, China launched the “Thousand Talents Plan,” which is aimed at attracting top researchers from across the globe.The government of China is reportedly asking officials to quiet down promotion of the program aimed at recruiting western scientists to work in that country.
PRESS RELEASES